BCG in bladder cancer – a warning
- 1 August 1995
- journal article
- Published by Wiley in Australian and New Zealand Journal of Medicine
- Vol. 25 (4) , 275-277
- https://doi.org/10.1111/j.1445-5994.1995.tb01888.x
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- The persistence of bacille Calmette‐Guerin in the bladder after intravesical treatment for bladder cancerBritish Journal of Urology, 1995
- Durability of the Tumor-Free Response for Intravesical Bacillus Calmette-Guerin TherapyJournal of Urology, 1994
- REACTIVE ARTHRITIS ASSOCIATED WITH BACILLUS CALMETTEGUERIN IMMUNOTHERAPY FOR CARCINOMA OF THE BLADDER: A REPORT OF TWO CASESRheumatology, 1993
- Disseminated Infection After Intravesical BCG ImmunotherapyChest, 1993
- MiliaryMycobacterium bovisInduced by Intravesical Bacille Calmette-Guérin ImmunotherapyAmerican Review of Respiratory Disease, 1992
- PRINCIPLES OF INTRAVESICAL CHEMOTHERAPY AND IMMUNOTHERAPYUrologic Clinics of North America, 1992
- COMPLICATIONS OF BACILLUS CALMETTE-GUÉRIN IMMUNOTHERAPYUrologic Clinics of North America, 1992
- A Randomized Trial of Intravesical Doxorubicin and Immunotherapy with Bacille Calmette–Guérin for Transitional-Cell Carcinoma of the BladderNew England Journal of Medicine, 1991
- An Overview of Intravesical Therapy for Superficial Bladder TumorsJournal of Urology, 1987
- Treatment for Muscle Invasive Carcinoma of the BladderJournal of Urology, 1986